News from Holden


New radiation therapy targets tumors more precisely

Software piloted at UI Health Care increases precision of MR-Linac technology  UI Health Care is the first


Drinkable, carbon monoxide-infused foam enhances effectiveness of experimental cancer therapy

Did smokers do better than non-smokers in a clinical trial for an experimental cancer treatment? That was the intriguing question that led University of Iowa researchers and their colleagues to develop a drinkable, carbon monoxide-infused foam that boosted the effectiveness of the therapy, known as autophagy inhibition, in mice and human cells. The findings were recently published in the journal Advanced Science.

From the Director

Dorfman Award Nominations

November 16, 2023 To: Holden Comprehensive Cancer Center Members


Holden oncologist receives NCI award for dedication to lung cancer clinical research

Muhammad Furqan, MD, medical oncologist in the University of Iowa Holden Comprehensive Cancer Center, is the recipie


Faculty awarded 2023 ACS seed grant through Holden Comprehensive Cancer Center

Four early-career scientists have each been awarded a one-year, $40,000 American Cancer Society Institutional Researc


Rare cancer care

Treating two girls with the same rare cancer is more than a coincidence for UI adult and pediatric specialists.

Innovation Research

Bladder cancer breakthrough

With the conventional first-line drug for early-stage bladder cancer in severe shortage, new therapies developed at Iowa are poised to lead a new wave of care.